Drug Type Small molecule drug |
Synonyms AR 806, AR-806, RDE-806 + [3] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H18BrClKN4O3S |
InChIKeyRERMWOUPIRSGFY-UHFFFAOYSA-N |
CAS Registry878670-63-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gout | Phase 2 | CA | 01 Jul 2008 | |
Hyperuricemia | Phase 2 | CA | 01 Jul 2008 | |
HIV Infections | Phase 2 | DE | 01 Jan 2008 | |
HIV Infections | Phase 2 | GB | 01 Jan 2008 |
Phase 2 | 48 | qlgmhduekz(ddehuvugmq) = ikkiqwrrdj ogemiuuyoz (ctdinjbokw ) | Positive | 01 Aug 2010 | |||
Not Applicable | 24 | tunvsvtmzp(ejciholdki) = opikrvghkb hzcbhgagxx (hqjxtwknto ) | Positive | 11 Jun 2008 | |||
tunvsvtmzp(ejciholdki) = bpqztjcctj hzcbhgagxx (hqjxtwknto ) | |||||||
Not Applicable | - | yninrlfezj(euivuqxnvf) = bqbisgudwh wuootkergz (jzigbualtf ) | Positive | 11 Jun 2008 | |||
Placebo | yninrlfezj(euivuqxnvf) = ceiwnxkzov wuootkergz (jzigbualtf ) |